Biochemical Signaling of PD-1 on T Cells and Its Functional Implications

被引:250
作者
Boussiotis, Vassiliki A. [1 ]
Chatterjee, Pranam [1 ]
Li, Lequn [1 ]
机构
[1] Harvard Univ, Sch Med, Canc Canter Beth Israel Deaconess Med Ctr, Dept Med,Div Hematol Oncol, Boston, MA USA
关键词
Controlling autoimmunity; T cell anergy; peripheral tolerance; PD-1; CYCLIN-DEPENDENT KINASES; PROGRAMMED DEATH-1; REGULATORY POLYMORPHISM; MEDIATED DEGRADATION; DISEASE PROGRESSION; PROTEIN STABILITY; DOWN-REGULATION; EXPRESSION; ACTIVATION; PATHWAY;
D O I
10.1097/PPO.0000000000000059
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Maintenance of peripheral tolerance is essential for homeostasis of the immune system. While central tolerancemechanisms result in deletion of the majority of self-reactive T cells, T lymphocytes specific for self-antigens also escape this process and circulate in the periphery. To control the development of autoimmunity, multiple mechanisms of peripheral tolerance have evolved, including T cell anergy, deletion, and suppression by regulatory T (Treg) cells. The pathway consisting of the programmed cell death 1 (PD-1) receptor (CD279) and its ligands PD-L1 (B7-H1, CD274) and PD-L2 (B7-DC; CD273) plays a vital role in the induction and maintenance of peripheral tolerance. This pathway also regulates the balance between stimulatory and inhibitory signals needed for effective immunity and maintenance of T cell homeostasis. In contrast to this important beneficial role in maintaining T cell homeostasis, PD-1 mediates potent inhibitory signals that prevent the expansion and function of T effector cells and have detrimental effects on antiviral and antitumor immunity. Despite the compelling studies on the significant functional role of PD-1 in mediating inhibition of activated T cells, little is known about how PD-1 blocks T cell activation. Here, we will provide a brief overview of the signaling events that are regulated by PD-1 triggering, and we will discuss their implications on cell intrinsic and extrinsic mechanisms that determine the fate and function of T effector cells.
引用
收藏
页码:265 / 271
页数:7
相关论文
共 81 条
[1]
Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes [J].
Agata, Y ;
Kawasaki, A ;
Nishimura, H ;
Ishida, Y ;
Tsubata, T ;
Yagita, H ;
Honjo, T .
INTERNATIONAL IMMUNOLOGY, 1996, 8 (05) :765-772
[2]
CD28 costimulation mediates transcription of SKP2 and CKS1, the substrate recognition components of SCFSkp2 ubiquitin ligase that leads p27kip1 to degradation [J].
Appleman, Leonard J. ;
Chernova, Irene ;
Li, Lequn ;
Boussiotis, Vassiliki A. .
CELL CYCLE, 2006, 5 (18) :2123-2129
[3]
CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells [J].
Appleman, LJ ;
van Puijenbroek, AAFL ;
Shu, KM ;
Nadler, LM ;
Boussiotis, VA .
JOURNAL OF IMMUNOLOGY, 2002, 168 (06) :2729-2736
[4]
CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression [J].
Appleman, LJ ;
Berezovskaya, A ;
Grass, I ;
Boussiotis, VA .
JOURNAL OF IMMUNOLOGY, 2000, 164 (01) :144-151
[5]
Phospholipase Cγ activates Ras on the Golgi apparatus by means of RasGRP1 [J].
Bivona, TG ;
Perez de Castro, I ;
Ahearn, IM ;
Grana, TM ;
Chiu, VK ;
Lockyer, PJ ;
Cullen, PJ ;
Pellicer, A ;
Cox, AD ;
Philips, MR .
NATURE, 2003, 424 (6949) :694-698
[6]
Boonen GJJC, 1999, EUR J IMMUNOL, V29, P789
[7]
The when and wheres of CDC25 phosphatases [J].
Boutros, R ;
Dozier, C ;
Ducommun, B .
CURRENT OPINION IN CELL BIOLOGY, 2006, 18 (02) :185-191
[8]
Blockade of programmed death-1 Ligands on dendritic cells enhances T cell activation and cytokine production [J].
Brown, JA ;
Dorfman, DM ;
Ma, FR ;
Sullivan, EL ;
Munoz, O ;
Wood, CR ;
Greenfield, EA ;
Freeman, GJ .
JOURNAL OF IMMUNOLOGY, 2003, 170 (03) :1257-1266
[9]
Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses [J].
Butte, Manish J. ;
Keir, Mary E. ;
Phamduy, Theresa B. ;
Sharpe, Arlene H. ;
Freeman, Gordon J. .
IMMUNITY, 2007, 27 (01) :111-122
[10]
SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 [J].
Carrano, AC ;
Eytan, E ;
Hershko, A ;
Pagano, M .
NATURE CELL BIOLOGY, 1999, 1 (04) :193-199